CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-15 | Hawkins Richard J Director | Sale | −10,409 | $11.16 | $116K | 0 |
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion | +21,682 | $0.52 | $11K | 21,682 |
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion | +586 | $0.52 | $305 | 22,268 |
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion | +2,288 | $0.52 | $1K | 24,556 |
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion | +444 | $0.55 | $244 | 25,000 |
| 2019-05-14 | Hawkins Richard J Director | Sale | −14,591 | $11.07 | $161K | 10,409 |
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion · Stock Option (Right to Buy) | −21,682 | 0 | ||
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion · Stock Option (Right to Buy) | −586 | 0 | ||
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion · Stock Option (Right to Buy) | −2,288 | 0 | ||
| 2019-05-14 | Hawkins Richard J Director | Exercise or conversion · Stock Option (Right to Buy) | −444 | 728 | ||
| 2019-05-02 | Lowrance David L Chief Financial Officer | Exercise or conversion | +3,700 | $1.51 | $6K | 3,700 |
| 2019-05-02 | Lowrance David L Chief Financial Officer | Sale | −3,700 | $10.82 | $40K | 0 |
| 2019-05-02 | Lowrance David L Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −3,700 | 80,684 | ||
| 2019-05-01 | Lowrance David L Chief Financial Officer | Exercise or conversion | +3,800 | $1.51 | $6K | 3,800 |
| 2019-05-01 | Lowrance David L Chief Financial Officer | Sale | −3,800 | $10.76 | $41K | 0 |
| 2019-05-01 | Lowrance David L Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −3,800 | 84,384 | ||
| 2019-04-08 | Lowrance David L Chief Financial Officer | Exercise or conversion | +4,734 | $1.51 | $7K | 4,734 |
| 2019-04-08 | Lowrance David L Chief Financial Officer | Sale | −4,734 | $9.04 | $43K | 0 |
| 2019-04-08 | Lowrance David L Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −4,734 | 88,184 | ||
| 2019-04-08 | Jouhikainen Jaakko Taneli President and COO | Sale | −16,336 | $9.04 | $148K | 167,569 |
Page 16 of 20 · 390 trades